Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
dabigatran (pradaxa) (1 trial)
Atrial Fibrillation (Phase 4)
Thromboembolism (Phase 4)
Trials (1 total)
Trial APIs (1 total)